Laurie Stelzer

Laurie Stelzer is currently the Executive Vice President and Chief Financial Officer of Arena Pharmaceuticals. Laurie has over 20 years of experience in biopharmaceutical management, including leading teams in finance, treasury, investor relations, business development and emerging markets. Most recently, Laurie served as Chief Financial Officer of Halozyme Therapeutics, Inc. Prior to joining Halozyme, Laurie served as SVP of Finance for R&D, Technical Operations and Business Development, and was previously Division CFO for Regenerative Medicine, at Shire Plc. Before Shire, she spent 15 years at Amgen Inc. in senior leadership roles in finance and business development with responsibilities including the U.S., Canada and International Markets, ultimately serving as the company’s acting treasurer, and playing an integral role in the original build of their immunology business. Laurie earned her B.S. in Accounting from Arizona State University and an M.B.A. from University of California, Los Angeles, Anderson School of Management. She currently serves on the board of directors for Surface Oncology, Inc.